Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan;62(1):111-6.
doi: 10.1111/jgs.12595.

Cost-effectiveness of cranberry capsules to prevent urinary tract infection in long-term care facilities: economic evaluation with a randomized controlled trial

Cost-effectiveness of cranberry capsules to prevent urinary tract infection in long-term care facilities: economic evaluation with a randomized controlled trial

Wilbert B van den Hout et al. J Am Geriatr Soc. 2014 Jan.

Abstract

Objectives: To investigate whether the preventive use of cranberry capsules in long-term care facility (LTCF) residents is cost-effective depending on urinary tract infection (UTI) risk.

Design: Economic evaluation with a randomized controlled trial.

Setting: Long-term care facilities.

Participants: LTCF residents (N = 928, 703 female, median age 84), stratified according to UTI risk.

Measurements: UTI incidence (clinically or strictly defined), survival, quality of life, quality-adjusted life years (QALYs), and costs.

Results: In the weeks after a clinical UTI, participants showed a significant but moderate deterioration in quality of life, survival, care dependency, and costs. In high-UTI-risk participants, cranberry costs were estimated at €439 per year (1.00 euro = 1.37 U.S. dollar), which is €3,800 per prevented clinically defined UTI (95% confidence interval = €1,300-infinity). Using the strict UTI definition, the use of cranberry increased costs without preventing UTIs. Taking cranberry capsules had a 22% probability of being cost-effective compared with placebo (at a willingness to pay of €40,000 per QALY). In low-UTI-risk participants, use of cranberry capsules was only 3% likely to be cost-effective.

Conclusion: In high-UTI-risk residents, taking cranberry capsules may be effective in preventing UTIs but is not likely to be cost-effective in the investigated dosage, frequency, and setting. In low-UTI-risk LTCF residents, taking cranberry capsules twice daily is neither effective nor cost-effective.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The state-transition model used in the economic evaluation. UTI = Urinary Tract Infection.
Figure 2
Figure 2
Cost-effectiveness acceptability curves, for high-urinary tract infection (UTI)-risk participants (the probability that cranberry use is more cost-effective than placebo, depending on how much one is willing to pay for a quality-adjusted life year (QALY), based on utility measured using the EQ-5D or the visual analog scale (VAS)).

Comment in

References

    1. Nicolle LE. Urinary tract infections in the elderly. Clin Geriatr Med. 2009;25:423–436. - PubMed
    1. Foxman B. Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs. Am J Med. 2002;113(Suppl 1A):5S–13S. - PubMed
    1. Ruben FL, Dearwater SR, Norden CW, et al. Clinical infections in the noninstitutionalized geriatric age group: Methods utilized and incidence of infections. The Pittsburgh Good Health Study. Am J Epidemiol. 1995;141:145–157. - PubMed
    1. Dwyer LL, Harris-Kojetin LD, Valverde RH, et al. Infections in long-term care populations in the United States. J Am Geriatr Soc. 2013;61:341–349. - PubMed
    1. Caljouw MA, van den Hout WB, Putter H, et al. Effectiveness of cranberry capsules to prevent urinary tract infections in vulnerable older persons. A double-blind randomized placebo-controlled trial in long-term care facilities. J Am Geriatr Soc. 2014:103–110. - PMC - PubMed

Publication types

Associated data